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AbstrACt
Tinnitus remains a scientific and clinical problem whereby, 
in spite of increasing knowledge on effective treatment 
and management for tinnitus, very little impact on clinical 
practice has been observed. There is evidence that 
prolonged, obscure and indirect referral trajectories persist 
in usual tinnitus care.
Objective It is widely acknowledged that efforts to 
change professional practice are more successful if 
barriers are identified and implementation activities 
are systematically tailored to the specific determinants 
of practice. The aim of this study was to administer 
a health service evaluation survey to scope current 
practice and knowledge of standards in tinnitus 
care across Europe. The purpose of this survey was 
to specifically inform the development process of a 
European clinical guideline that would be implementable 
in all European countries.
Design A health service evaluation survey was carried 
out.
setting The survey was carried out online across Europe.
Participants Clinical experts, researchers and policy- 
makers involved in national tinnitus healthcare and 
decision- making.
Outcome measures A survey was developed by the 
study steering group, piloted on clinicians from the TINNET 
network and underwent two iterations before being 
finalised. The survey was then administered to clinicians 
and policy- makers from 24 European countries.
results Data collected from 625 respondents revealed 
significant differences in national healthcare structures, 
use of tinnitus definitions, opinions on characteristics 
of patients with tinnitus, assessment procedures and 
particularly in available treatment options. Differences 
between northern and eastern European countries were 
most notable.
Conclusions Most European countries do not have 
national clinical guidelines for the management of tinnitus. 
Reflective of this, clinical practices in tinnitus healthcare 
vary dramatically across countries. This equates to 
inequities of care for people with tinnitus across Europe 
and an opportunity to introduce standards in the form of 
a European clinical guideline. This survey has highlighted 
important barriers and facilitators to the implementation of 
such a guideline.
IntrODuCtIOn
Tinnitus, the perception of a phantom 
sound, is a widespread auditory symptom.1 
It can occur with several audiological and/
or otological disorders, such as sensorineural 
hearing loss. In rare cases, tinnitus can be 
traced to an underlying pathology, though 
uniform aetiology remains undetermined.2 
Epidemiological findings are difficult to pool 
across studies due to differences in methodol-
ogies.3 Nonetheless, assuming a conservative 
tinnitus prevalence of 10% (severe tinnitus 
of 1%), tinnitus affects more than 42 million 
European Union (EU) adults and is a severe 
problem for more than four million adults. 
According to data from two large cohorts 
from Wisconsin (USA), tinnitus prevalence 
is increasing over time (on average by 1.4% 
each 5- year birth cohort).4 Assuming this 
increase is linear and of similar magnitude, 
prevalence estimates will double by 2050.
Tinnitus is residing within and confined to 
the individual’s subjective perceptual experi-
ence, not measurable or quantifiable by objec-
tive physical recordings, and furthermore 
strengths and limitations of this study
 ► This is the first and only pan- European health ser-
vice evaluation to scope current practice and clinical 
standards in tinnitus healthcare.
 ► Results provide health service information and ex-
pert opinions on national healthcare structures, re-
flecting a truly pan- European point of view.
 ► Results define important barriers and facilitators to 
propel development and implementation of mean-
ingful and actionable guidelines.
 ► Two of the 24 countries who participated had many 
more respondents than others, possibly influencing 
data excessively.
 ► Most respondents were otologists, which might indi-
cate lesser involvement of other disciplines in tinni-
tus healthcare at present and under- representation 
of viewpoints in results.
copyright.
 o
n
 January 27, 2020 at University of Nottingham
. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029346 on 21 January 2020. Downloaded from 
2 Cima RFF, et al. BMJ Open 2020;10:e029346. doi:10.1136/bmjopen-2019-029346
Open access 
Table 1 Classification and percentage of respondents 
according to region; 1=North, 2=South, 3=East
Country Region
n per 
country
n per 
region Total %
Region 1 216 34.6
Austria 1 1
Belgium 1 54
Denmark 1 14
Finland 1 1
France 1 39
Germany 1 28
The Netherlands 1 41
Sweden 1 23
Switzerland 1 3
UK 1 12
Region 2 225 36.0
Cyprus 2 2
Greece 2 29
Italy 2 50
Israel 2 12
Malta 2 9
Portugal 2 64
Spain 2 59
Region 3 184 29.4
Albania 3 2
Croatia 3 2
Czech Republic 3 68
Lithuania 3 82
Poland 3 19
Serbia 3 8
Slovenia 3 3
Total 625 625 100
very rarely traceable to disease, injury or pathology in 
the brain or elsewhere. Even though knowledge on the 
pathophysiology of tinnitus has made some progress,5 6 
there is still little evidence for effective curative tinnitus 
treatments or licensed pharmacological therapy.7 The 
Cochrane Library currently includes nine systematic 
reviews on different tinnitus treatments,8 all of which are 
reported to have little, if any, quality evidence.9 Patients 
report difficulties in concentration, being anxious and 
distressed, difficulty sleeping, being interrupted in their 
daily tasks, and feeling helpless and despondent most of 
the time. A wide range of evidence corroborates the theory 
that cognitive misinterpretations, negative emotional 
reactivity and dysfunctional attentional processes are of 
main importance to the severe tinnitus condition.10–20
From a scientific and clinical perspective, the increased 
knowledge on treatment and management for tinnitus 
has had minimal impact on clinical practice.2 There is 
evidence that prolonged, obscure and indirect referral 
trajectories persist in usual tinnitus care.21 Tinnitus is 
indeed a highly complex condition with a multifacto-
rial origin. Heterogeneous patient profiles lead to a 
lack of consensus on standard assessment and treat-
ment approaches, which in turn again lead to increasing 
complaints, prolonged suffering and endless referral 
trajectories, resulting in enormous psychological, societal 
and economic burden.22
In 2014, the EU approved funding for a 4- year COST 
Action (TINNET) to create a pan- European tinnitus 
research network. TINNET’s working group 1 (WG1) 
consists of clinical and academic experts in tinnitus 
from across Europe whose joint objective is to develop 
meaningful and actionable clinical guidelines for the 
assessment and treatment of patients with tinnitus, and 
to provide a consensus- based clinical definition and char-
acterisation of tinnitus (http:// tinnet. tinnitusresearch. 
net/ index. php/ 2015- 10- 29- 10- 22- 16/ wg- 1- clinical). Ulti-
mately, a European multidisciplinary clinical guideline 
would be a first step toward a common minimum stan-
dard of care for patients with tinnitus across Europe.23 
To ensure from a development perspective that a Euro-
pean guideline would become implementable, it became 
essential to scope current existence and knowledge of 
standards in tinnitus care across the continent. Without 
knowledge on the current ‘state of the art’ and standards 
in tinnitus healthcare, a consensus- based, meaningful 
and actionable guideline could not be ensured. It is 
widely acknowledged that efforts to change professional 
practice are more successful if barriers are identified and 
guidelines for implementation activities are systematically 
tailored to the specific determinants of practice.24 As such, 
a pan- European survey of clinicians and policy- makers 
was carried out to gain service information and expert 
opinions on national healthcare structures, tinnitus defi-
nition, general characteristics of patients with tinnitus, 
and assessment and treatment options.
MethODs
The method for scoping current knowledge, opinion 
and practices in tinnitus care across Europe, a web- based 
survey was developed by consensus of members within 
TINNET WG1. Participation was on a voluntary basis and 
all data were submitted anonymously.
survey development
The survey was developed during three consecutive WG1 
meetings. It was agreed that the survey would be devel-
oped in the English language, since it was expected that 
most responders would be able to understand English, 
irrespective of the country of origin. The development 
involved two phases. First, based on their shared knowl-
edge of tinnitus, nine members of the WG1 steering 
group generated a list of domains of interest, formu-
lated a set of questions for each domain and generated 
a set of response options for each question. This list of 
questions was subsequently piloted in a larger group 
of WG1 members (n=81) via email, and during a WG1 
copyright.
 o
n
 January 27, 2020 at University of Nottingham
. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029346 on 21 January 2020. Downloaded from 
3Cima RFF, et al. BMJ Open 2020;10:e029346. doi:10.1136/bmjopen-2019-029346
Open access
Figure 1 Responses from each participating country.
management meeting. Consensus rounds were used to 
either include or exclude items. The remaining survey 
items were then re- disseminated to all WG1 members 
who had been involved in the development and piloting 
stages with a request to provide comments on any neces-
sary alterations, changes to wording or response options 
and for any general remarks. A final survey was agreed 
on and produced for online dissemination using Google 
forms. The final survey contained items grouped as (1) 
demographics, (2) national healthcare structure, (3) 
tinnitus definitions and characteristics of the patient with 
tinnitus and (4) management, treatment and diagnostics.
Participants
The recruitment targeted clinical experts, researchers 
and policy- makers involved in national tinnitus health-
care and decision- making. A total of 625 participants 
were recruited using the COST- TINNET network. First, 
members of the management committee of TINNET 
were contacted via email with a link to the survey (online 
supplementary information 1 provides the questions used 
in the survey) and were requested to forward the invita-
tion to clinical experts, researchers and tinnitus- organ-
isations in their respective countries (n=24; table 1). 
Second, another round of targeted dissemination was 
performed in July 2015, as at that time it was noted that 
there was a lower response rate from some countries. 
The low response rate from Italy and Spain was identi-
fied as being a language barrier and therefore the survey 
was translated by native- speaking TINNET members and 
redistributed in their national language. The reason for 
low responses from other countries was not identified. 
The survey was open from January to October 2015.
Patient and public involvement
The aim of the current study falls within the frame-
work and main aims of the COST TINNET project. The 
project, and in particular working package 1, focused 
on the objective ‘Clinical and audiological assessment of 
patients with tinnitus according to common standards’. 
The current study was an essential step in the roadmap 
toward the aim of the project.25 In the development and 
execution of the TINNET project, patient organisations 
throughout Europe were consulted and were actively 
involved in several stages. In the current survey, no indi-
vidual patients were recruited, nor were they involved, 
since this study involved the evaluation of health services 
by clinicians, policy- makers and individual professional 
expert opinions on national healthcare structures. Results 
of the current study were disseminated to all existing 
European patient organisations using a Delphi consensus 
methodology in the development of harmonised and 
adaptive clinical European guidelines for tinnitus enti-
tled ‘Multidisciplinary European Guideline for Tinnitus: 
Diagnostics, Assessment and Treatment’.23 These have 
been presented to the scientific community as well as 
national patient organisation symposia.
Analyses
Results were first described and depicted descriptively. 
Because the number of responses from each country 
differed, data were stratified according to whether the 
country was in northern (higher income), southern 
(moderate income) or eastern (lower income) Europe 
(table 1) (online supplementary information 2 gives the 
average monthly net income per country and per region). 
The rationale for this classification was that economic 
prosperity might lead to differences in healthcare for 
patients with tinnitus, since lesser resources indicate 
lower availability of specialised healthcare. One- way anal-
ysis of variance and regression analyses were performed 
to assess differences and associations between variables 
in northern, southern and eastern countries. All analyses 
were performed in IBM- SPSS V.23.
results
Demographics
Survey responses (n=625) were received from partici-
pants across 24 countries (figure 1) with a large number 
of participants from Lithuania, Czech Republic, Portugal 
and Spain. The mean age of respondents was 43.9 years 
(SD=12.4), 49.7% were male and 50.3% were female. 
Respondents were from many disciplines (figure 2) and 
worked in public healthcare (n=291), private healthcare 
(n=199), university (n=89) or other setting (n=48). Some 
respondents reported more than one workplace (n=213).
national healthcare structure
Across all three regions of Europe, tinnitus healthcare 
was in most cases financed by national health insur-
ances. This was particularly evident for eastern countries, 
where 90.8% of respondents reported that their service 
is publicly funded. Privately funded treatment was most 
common in southern Europe (48%) (online supplemen-
tary information 3).
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Figure 2 Discipline of respondents. GP, general practitioner.
The most common referral pathways and the descrip-
tion of services and patient’s status are given in figure 3 
and table 2, respectively. In taking a regional perspec-
tive, difference across Europe became clear. Specialised 
tinnitus clinics (or teams) were perceived to be most 
present in the northern regions (more than 50% of 
respondents confirmed), where referral by ENT and/
or audiology seems common. Whereas in southern 
Europe, many people appeared to self- refer to specialists, 
in eastern Europe referral opinions varied or were less 
understood by respondents. More northern European 
respondents reported having and using clinical guide-
lines (online supplementary information 4) than respon-
dents from southern or eastern Europe.
Tinnitus, definitions and characteristics of the patient with tinnitus
In all regions, more experts reported that, in their opinion, 
tinnitus is either a central auditory symptom (table 2). 
Still, more than 10% from all regions considered tinnitus 
a disease, whether auditory or psychological. Differences 
were found between higher and lower income regions 
with respect to the perceived emotional status of their 
‘typical’ patients (table 2) and the time spent with indi-
vidual patients during the first consultation (table 3). The 
majority of respondents from northern Europe (41.7%) 
reported spending between 30 and 60 min with patients 
with tinnitus on the first appointment, in contrast to 43.9% 
in the south and 56% in the east spending between 15 
and 30 min. Patients in northern Europe were evaluated 
as being more often ‘somewhat distressed’ in comparison 
to a more ‘neutral’ status in the south and east (see also 
online supplementary information 5).
Management, treatment and diagnostics
All treatments available within their respective depart-
ments were reported (table 4). Where medication was 
selected as an available option, the respondent were 
asked to indicate the specific drug in the ‘other’ free- 
text space. Here, sound therapy is taken to include the 
use of hearing aids, and Tinnitus Retraining Therapy 
includes any reportedly modified version of the 
treatment.
Medications used in tinnitus treatment included 
betahistine, steroids, vasodilators, antidepressants 
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Figure 3 Most common referrals according to region. ENT, 
ear, nose and throat.
and anxiolytics. ‘Other’ treatment options reported 
as available were hyperbaric chamber therapy, laser 
therapy, transcranial direct current stimulation, Gingko 
biloba, vitamin B12, hypnosis, sleep hygiene, osteopathy, 
cochlear implantation and music therapy. Differences 
in treatment availability across regions were striking, 
particularly between the north and east. Indicative of the 
general trends, cognitive–behavioural therapy was avail-
able from 34.3% of departments in northern Europe, 
compared with just 4.9% in the east. In contrast, medi-
cation was an option in 79.9% of the departments in 
the east, whereas only 27.3% used medications in the 
north. While medication was the most commonly avail-
able treatment option in the east, in both the north and 
south it was sound- based therapy (in 69.9% and 68.4% 
of departments, respectively).
Clinicians involved in tinnitus care ranged from 
just one discipline to a broad multidisciplinary team 
(table 5). Multidisciplinary treatments (MDTs) and 
having a psychologist in the team was more common in 
northern countries than in the east and south. In the 
east, most care appears to be delivered by medical profes-
sionals (otolaryngologists or neurologists). Other disci-
plines involved in tinnitus care, reported by 1%–2% of 
respondents, included prosthetists, social workers, move-
ment therapists, osteopaths, sophrologists, psychosomatic 
medicine specialists, acupuncturists, hearing therapists, 
ophthalmologist, dance movement therapists, general 
practitioners (GPs), cardiologists, maxillofacial surgeons 
and radiologists. There were single reports of an arts ther-
apist, counsellor, speech therapist, mindfulness instructor 
and hypnotherapist being involved in care.
Conditions and or symptoms perceived as being of rele-
vance when assessing and/or treating tinnitus are given in 
table 6. Most respondents reported hearing loss and dizzi-
ness complaints as relevant, irrespective of the region.
Other conditions frequently reported by respondents 
as of relevance to tinnitus were suicidal tendency, otitis, 
eustachian tube dysfunction, acoustic neuroma, multiple 
sclerosis and coagulation disorder. A minority (≤1%) 
additionally reported hyperacusis, autoimmune disease, 
neurovascular conflict, Pendred syndrome, stress, 
psychosis, nasal septal deformation, vascular disease, 
facial pain, sensory hypersensitivity, cardiac arrhythmia, 
arterial stenosis, sleep disorders, hypercholesterolaemia, 
fibromyalgia, apnoea and rhinosinusitis.
There was a general consensus on the diagnostic tools 
to be used to assess patients with tinnitus in clinical prac-
tice (table 7). Most respondents reported that otoscopy 
and pure tone audiometry were used. There was some 
variability in the reported use of other diagnostic tools; 
for example, percentage use of audiological assessments 
such as tympanometry or speech audiometry in the north 
was twice than that in the east. ‘Other’ responses included 
clinical interview, Diagnostic and Statistical Manual of 
Mental Disorders, vestibular- evoked myogenic potential, 
brainstem- evoked response audiometry, tone decay, neck 
vessel ultrasonography, orthopantomography, blood anal-
ysis, vestibular testing (calorimetry), blood pressure and 
auditory brainstem response, all of which were reported 
by ≤3% of respondents.
Most respondents from northern and southern 
countries reported using some form of multi- item 
questionnaire, in comparison with only about one in 
five respondents from eastern European countries 
(figure 4). The most frequently used questionnaire, 
irrespective of region was the Tinnitus Handicap Inven-
tory (THI).26 Interestingly, the only anxiety/depression 
questionnaire used was the Hospital Anxiety and Depres-
sion Scale27 and only in eastern countries. The Tinnitus 
Questionnaire28 was mentioned frequently in northern 
and southern regions. The more recently developed 
Tinnitus Functional Index29 was only mentioned in 
the north. Additionally, respondents from all regions 
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Table 2 View of ‘tinnitus’ and emotional status of patients, classified according to region
North South East
Sign.n % n % n %
What is tinnitus?
A central auditory disease 8 3.7 9 4.0 17 9.2
A central auditory symptom 88 40.7 64 28.4 37 20.1
A peripheral auditory disease 11 5.1 17 7.6 12 6.5
A peripheral auditory symptom 100 46.3 126 56.0 110 59.8
A psychological disease 4 1.9 1 0.4 5 2.7
Combination/multiple causes/other 5 2.3 6 2.7 3 1.6
Cannot answer/does not know 2 0.9
Chronic or acute? n.s.
Chronic (>3 months) 123 56.9 144 64.6 104 56.5
Acute (<3 months) 19 8.8 18 8.1 27 14.7
Both 74 34.3 61 27.4 53 28.8
Emotional status of most patients †
Very positive 1 0.5 0 0 5 2.7
Somewhat positive 22 10.2 22 9.9 25 13.6
Neutral 56 25.9 102 45.7 96 52.2
Somewhat distressed 113 52.3 87 39.0 43 23.4
Very distressed 24 11.1 12 5.4 15 8.2
*Difference between north compared with south and east (α<0.05).
†Different between all groups (α<0.05).
n.s., not significant; Sign., significant difference.
Table 3 Appointment duration and number of patients per month, classified according to region
North South East Sign. †
n % n % n % *
Duration of the first consultation
Less than 15 min 23 10.6 37 16.6 55 29.9
15 to 30 min 51 23.6 98 43.9 103 56.0
30 to 60 min 90 41.7 58 26.0 21 11.4
60 to 120 min 44 20.4 25 11.2 5 2.7
More than 120 min 8 3.7 5 2.2 0 0
No of patients per month *
≤10 73 33.8 117 52.2 101 54.9
11–30 96 44.4 87 38.8 61 33.2
31–50 33 15.3 12 5.4 9 4.9
>50 14 6.5 8 3.6 13 7.1
*Different between all groups (α<0.05).
†Difference between north compared with south and east (α<0.05).
Sign, significant difference.
specified to use Visual Analogue Scales (though unspec-
ified which) as well. Questionnaires reported as ‘other’ 
were unspecified.
Finally, regarding the satisfaction rate on the service 
provided by their healthcare unit, 81.7% respondents 
from the north, 38.5% from the south and 35.0% from 
the east reported they were satisfied. In northern Europe, 
professionals were largely satisfied, whereas in southern 
and eastern Europe, opinions were more divided, and 
less than half of respondents claimed to be satisfied.
regression analyses
Regression analyses were conducted to establish whether 
there were statistically significant associations between 
average net income of the country of origin of respon-
dents and the presence of specialised tinnitus clinics, 
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Table 4 Treatments reported as available within respondents’ departments, reported by region
North (n) % South (n) % East (n) %
Advice 2 0 0 0 0 0
Alternative therapies 16 7.5 33 14.7 19 10.3
CBT 74 34.3 35 15.6 9 4.9
Counselling 108 50 115 51.1 41 22.3
Coping training 0 0 0 0 0 0
Dental procedure 2 0.9 0 0 0 0
Medication 59 27.3 111 49.3 147 79.9
Mindfulness 5 2.3 0 0 0 0
Neurofeedback 16 7.4 13 5.8 9 4.9
Physiotherapy 52 24.1 27 12 59 32.1
Relaxation 108 50 71 31.6 34 18.5
rTMS 14 6.5 3 1.3 3 1.6
Sound therapy 151 69.9 154 68.4 49 26.6
TRT 1 0.5 69 30.7 29 15.8
CBT, cognitive–behavioural therapy; rTMS, repetitive Transcranial Magnetic Stimulation; TRT, Tinnitus Retraining Therapy.
Table 5 Disciplines involved in tinnitus care
North % South % East %
ENT 118 54.6 43 19.1 87 47.3
Audiologist 132 61.1 39 17.3 57 31
Psychologist 136 63 32 14.2 24 13
Psychiatrist 33 15.3 39 17.3 39 21.2
Physiotherapist 19 8.8 3 1.3 3 1.6
Neurologist 20 9.3 19 8.4 81 44
Dentist 3 1.4 1 0.4 0 0
ENT, ear, nose and throat.
time for patients with tinnitus per consult, satisfaction 
of the respondent with their service, number of patients 
seen per month, the requirement of a referral by GP in 
their country and whether or not clinical guidelines exist. 
Significant associations were found between net income 
per month and all variables in the model (table 8). In 
summary, higher income was associated with more 
specialised clinics, longer appointment times, greater 
satisfaction with healthcare options, fewer patients per 
month, more referral necessity by GP, and more knowl-
edge and use of clinical guidelines.
DIsCussIOn
This survey sought to collate details and opinions on 
healthcare structure and clinical practices for tinnitus 
across Europe. The first interesting result from the 
survey was the difference between regions of Europe in 
terms of whether specialist tinnitus clinics were present. 
In the northern countries of Europe, most respondents 
confirmed the presence of specialised tinnitus clinics, 
in the South about half confirmed having specialist 
centres and in the East most respondents reported not 
having specialised clinics. That there seems to be discord 
in knowledge or opinions in the rest of Europe is inter-
esting. Where there are indeed specialised clinics, which 
professionals are aware of, they might more easily refer 
patients to these clinics without the need for a GP. On 
the other hand, when fewer clinics are present or known, 
tinnitus care more often falls to the GP, who might 
refer to a specialist, but not necessarily to a specialised 
centre. Opinions differed on whether a referral from a 
GP is necessary; the majority of respondents from eastern 
Europe reported that it is indeed the case, whereas in 
northern and southern Europe less than half of respon-
dents thought so. These findings indicate the importance 
of knowing the referral path. Addressing the lack of 
clinician’s knowledge is key in the development of mean-
ingful and actionable European guidelines. The lack of 
knowledge of existing specialised clinics also points to 
difficulties patients are likely to encounter in identifying 
the most appropriate healthcare. An uncertain health-
care journey and the lack of clear referral pathways is 
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Table 6 Opinions on which conditions are taken into consideration in tinnitus diagnostics
North % South % East %
Hypertension 98 45.4 118 52.4 79 42.9
Diabetes 45 20.8 108 48 55 29.9
Thyroid dysfunction 0 0 1 0.4 0 0
TMJ disorders 92 42.6 125 55.6 28 15.2
Psychological/psychiatric disorders 155 71.8 163 72.4 73 39.7
Hearing loss 212 98.1 221 98.2 159 86.4
Hyperlipidaemia 16 7.4 61 27.1 31 16.8
Dizziness 191 88.4 200 88.9 161 87.5
Cervical disorders 100 46.3 98 43.6 94 51.1
Migraine 72 33.3 83 36.9 41 22.3
Allergy 21 9.7 35 15.6 11 6
TMJ, Temporomandibular Joint.
Table 7 Diagnostic tools used for patients with tinnitus
North % South % East %
Otoscopy 169 78.2 211 93.8 135 73.4
Tympanometry 142 65.7 172 76.4 56 30.4
Nasal endoscopy 37 17.1 87 38.7 147 79.9
Pure tone audiometry 162 75 186 82.7 151 82.1
High- frequency audiometry 64 29.6 48 21.3 27 14.7
Speech audiometry 119 55.1 93 41.3 44 23.9
Tinnitus pitch and loudness 95 44 86 38.2 46 25
LDL 2 0.9 1 0.4 0 0
MML 1 0.5 0 0 0 0
RI 1 0.5 0 0 0 0
Broadband noise EP 0 0 0 0 0 0
Pure tone EP 0 0 0 0 0 0
(DP)OAE 68 31.5 54 24 35 19
AC- ASSR 9 4.2 18 8 4 2.2
Electroencephalogram 14 6.5 3 1.3 16 8.7
CT 17 7.9 34 15.1 44 23.9
MRI 76 35.2 119 52.9 100 54.3
Angio- MRI 28 13 37 16.4 19 10.3
AC_ASSR, Air Conduction - Auditory Steady State Response; DP(OAE), Distortion Product (Oto- Acoustic Emissions) ; EP, Evoked Potential; 
LDL, Loudness Discomfort Level; MML, Minimum Masking Level; RI, Residual Inhibition.
likely to exacerbate ongoing tinnitus distress, severity and 
chronicity.
In terms of national healthcare structure, the typical 
pathways differed by region. In the north, they most 
commonly include specialised audiologists and otolar-
yngologists, who can presumably refer onto specialist 
centres where available. In southern Europe, it was more 
common that people self- refer for tinnitus care. In eastern 
Europe, referral pathways were either less understood or 
less well- defined.
When asked which disciplines usually ‘handle’ patients 
with tinnitus, the mix of disciplines reported was more 
evenly distributed across the counselling and medical 
professions in northern countries than other regions, 
that is, tinnitus care was not more associated with one 
type of healthcare professional than another. In contrast, 
in southern and eastern countries it was reported that 
medical and technical professionals were most commonly 
involved. Interestingly this indicates a tendency toward a 
‘psychological’ approach in the north compared with a 
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Figure 4 Main questionnaire used per region. HADS, 
Hospital Anxiety and Depression Scale; TFI, Tinnitus 
Functional Index; THI, Tinnitus Handicap Inventory; TQ, 
Tinnitus Questionnaire.
more curative approach in tinnitus treatment in the other 
regions. Since there is ample evidence that psychological 
therapy is beneficial in any tinnitus treatment approach, 
and that there are regions in Europe where this is not 
provided, these findings highlight a second barrier to the 
adoption and implementation of a Europe wide practice 
guideline.
In all regions, most experts reported that in their 
opinion tinnitus is a central auditory symptom, which 
might indicate agreement between the regions, and 
offers a first facilitator. This data will be useful in achieving 
a consensus definition of tinnitus within a European 
guideline. Interestingly, respondents from northern 
countries more often reported their average patients to 
be distressed, whereas most respondents from the south 
and east judged their patients to be neither distressed nor 
‘positive’, but to be of a ‘neutral’ emotional status. This 
could indicate that in the north, the range of patients that 
are seen by experts is broader, that is, patients with milder 
as well as more severe tinnitus are assessed by specialists. 
It is also possible that since northern countries dedicate 
more time per patient, physicians are more able to assess 
levels of distress. It might also reflect a greater awareness 
of the emotional distress of patients since in the north, 
a psychological assessment including clinical question-
naires is more often conducted. This is of interest because 
the level of distress of patients with tinnitus is an important 
indicator of the need for onward referral for subsequent 
treatment options. A third barrier to the implementation 
of a European guideline may therefore be that in most 
regions of Europe, professionals responsible for patients 
with tinnitus do not have a sufficient amount of time to 
adequately assess the level of distress of their patients.
The presence of an MDT teams for tinnitus in northern 
regions was reported in most cases, including a psycholo-
gist working in most teams. By region however, it is noted 
that in the south many respondents report that there 
are no MDT teams, and in the east there was almost no 
psychologists involved in treatment. These findings repre-
sent a major fourth barrier in developing the develop-
ment of meaningful and actionable European guidelines, 
if the guideline is to include evidence- based healthcare.
There is consensus across the regions on which condi-
tions are important in tinnitus. Most respondents, irre-
spective of region, reported hearing loss, acoustic trauma 
and vertigo as the most relevant conditions to consider 
in the assessment of tinnitus. This consensus represents a 
second facilitator in discussions on and implementation 
of European guidelines.
The treatment options reported by respondents also 
showed clear trends according to region. This finding can 
be classified as a fifth barrier, in that it might be difficult to 
get consensus on what works for whom when many treat-
ment avenues are preferentially made available. When 
developing a guideline, it is of importance to provide 
clear indications on which treatments are recommended, 
which are not recommended and which have insufficient 
evidence to make a recommendation in either direction.30
There was consensus on the diagnostic tools to be 
used to assess patients with tinnitus in clinical practice. 
Although some small differences in procedures were 
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box 1 summary of barriers and facilitators
barriers
1. Lack of knowledge about or non- existence of specialised tinnitus 
clinics or teams makes it difficult for patients with tinnitus to find 
their way to the most appropriate professionals in a country.
2. Lack of time or other resources for adequate counselling.
3. Lack of time or other resources for professionals responsible for 
patients with tinnitus to be able to adequately assess the distress 
level of patients with tinnitus.
4. Lack of multidisciplinary teams and/or availability of psychologists 
in southern and eastern European countries.
5. High variation in available treatment options; more medical- 
pharmacological treatment in southern and eastern countries. 
Psychological- rehabilitative approaches more available in northern 
countries. When many treatment avenues are considered viable, it 
may be difficult to reach consensus on what works for whom.
6. The use of self- report instruments is much less common in southern 
and eastern countries.
7. There are differences in how patients pay for treatment. If regulatory 
bodies in healthcare in a country are unwilling or unable to hold to 
the restrictions or recommendations stated in a guideline, the likeli-
hood of implementation of this guideline is lower.
Facilitators
1. Common ground in expert opinion that tinnitus is a central auditory 
symptom. This offers options for discussions on the definition of tin-
nitus in a European guideline.
2. Consensus across regions on what conditions are relevant or asso-
ciated with tinnitus. Harmonies such as these are to be highlighted 
where possible to facilitate implementation of a standard guideline.
3. Though some small differences in procedures were reported, most 
experts use otoscopy and pure tone audiometry. Findings will facili-
tate discussions on diagnostics to include in the guidelines.
4. The most commonly used questionnaire irrespective of region is the 
Tinnitus Handicap Inventory. This may facilitate discussions on as-
sessment methods to recommend within a guideline.
5. The percentage of respondents satisfied with current tinnitus health-
care in their country in southern and eastern Europe was low; less 
than half of respondents reported they were satisfied. Healthcare 
professionals are likely to be positive toward progressive guidelines 
and toward changes in healthcare for tinnitus.
Table 8 Associations between income and tinnitus care
Model
Change statistics
Beta
Significant 
F changeR2 change F change df1 df2
Age/gender 0.007 1.989 2 605 −0.033 0.138
Specialised clinic 0.266 220.407 1 604 −0.516 0.000
Time per consult 0.106 102.780 1 603 0.334 0.000
Satisfaction healthcare 0.048 50.505 1 602 −0.235 0.000
Patients per month 0.015 15.728 1 601 0.124 0.000
GP necessary 0.010 10.507 1 600 −0.106 0.001
Clinical guidelines 0.008 9.272 1 599 0.094 0.002
Regressions summary: Dependent=income, Independents=Specialised clinics present, time per consult, Satisfaction of respondent with 
healthcare, Patients seen per month, necessity of referral by GP, existence of clinical guidelines, controlled for age and gender.
Coding: Specialised clinic: Yes=0, No=1; Time per consult: 1=<15 min, 2=15–30 min, 3=30–60 min, 4=60–12 min, 5=>120 min; Satisfaction 
healthcare: Yes=0, No=1; GP necesary: Yes=0, No=1; Clinical guidelines: Yes=0, No=1. Dependent: income.
GP, general practitioner.
reported, most experts use otoscopy and pure tone 
audiometry. There is some variability in the use of other 
diagnostic tools suggesting a potential third facilitator to 
discussions, on the inclusion of standardised diagnostic 
procedure in the guidelines.
A sixth barrier to standardised practice emerging from 
our data may be the limited use of clinical question-
naires in eastern and southern countries. Yet consensus 
exists that in research as well as the clinic questionnaires 
are key in assessment, both for screening and moni-
toring treatment progress.2 31 The most commonly used 
questionnaire however, irrespective of region, was the 
THI. This finding is consistent with a previous study.32 
This might offer a fourth facilitator to discussions, on 
primary outcome measures to recommend within a 
guideline.
When asked how patients pay for treatment, respon-
dents from southern and eastern Europe reported fewer 
patients pay privately for their tinnitus healthcare. None-
theless, in all regions, tinnitus treatments were financed 
by national health insurance schemes. This may become 
restrictive if health insurance companies have a strong 
influence on what tinnitus treatment options are made 
available within a country. When patients pay for treat-
ment privately, more treatment options might be on offer, 
even without adequate evidence of effectiveness. That 
there are differences in how patients pay for treatment 
is a seventh barrier to standard care across Europe, and 
a difficult one. In cases where the regulatory bodies in 
healthcare in a country are unwilling or unable to hold 
to the restrictions or recommendations stated in a guide-
line, the chances of implementation of this guideline 
drastically decrease.
Less than half of respondents from the south and 
east of Europe reported they were satisfied with current 
tinnitus healthcare in their country. This dissatisfaction 
may represent a fifth facilitator in that professionals are 
likely to be positive about progressive guidelines and 
toward changes in healthcare for tinnitus.
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Finally, economic prosperity in a country often defines 
healthcare organisation and healthcare satisfaction.33 In 
the current study, it was hypothesised that the economic 
resources available to individuals in a country might 
dictate the view of professionals on levels of advance-
ment in healthcare for tinnitus. This was indeed the case. 
Lower average net income in the country of origin of 
respondents was associated with reports of less specialised 
tinnitus healthcare, fewer specialised tinnitus clinics, less 
time for patients with tinnitus per consult and more often 
a lack (or use) of guidelines. Lower average income was 
also associated with lower satisfaction of the respondent 
with healthcare, and more necessity of referral by a GP. 
Interestingly, higher average net income in a country was 
associated with seeing more patients per month.
Some additional points are worthy of discussion. First, 
from the 24 countries who participated in the survey, 
some had many more respondents than others. This issue 
was presently solved by stratifying the countries according 
to region of Europe to yield similar respondent numbers 
per region. Nevertheless, responses from Lithuania and 
the Czech Republic might have a strong influence on 
the eastern region data, because of the large number of 
respondents from these countries. Second, most respon-
dents were otologists. The large (over)representation of 
this discipline might indicate that other disciplines are 
less involved in tinnitus healthcare, and that current 
reports rely heavily on the clinical views and experiences 
of otologists and might not reflect views or opinions of 
professionals of other disciplines. Third, it is important to 
note that the current findings do not necessarily indicate 
or reflect a right or wrong in the organisation of tinnitus 
healthcare, the available assessment and treatment 
options for tinnitus in a country or the advancement of 
specialised healthcare in a country. It is important that 
the current results are seen in the light of establishing 
potential facilitators and barriers (see box 1 below for 
summary) to the development and implementation of a 
guideline that can serve the whole of Europe, by being 
meaningful and actionable, and offer advice and options 
for professionals in the field, and the patients they care 
for.
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